Seracare/ACCURUN® 130 Lyme IgG Positive Control/20150080/1 × 1.0 mL

ACCURUN130LymeIgGPositiveControlisanexternalcontrolforusewithinvitroserologyassaysthatdetectIgGantibodiestoBorreliaburgdorferi(themaincauseofLymedisease).ACCURUN130canhelpyouavoidcostlyrepeatsand,moreimportantly,falsenegativeorpositiveresultsbyallowingyoutomonitoryourLymeassaywithareliablesourceoflowpositivematerial.

ACCURUN130

• Aready-to-usecontrolformulatedtobeweaklyreactive;helpschallengeyourassay,providesadditionalconfidenceinyourlab’stestresults
• AbletobecombinedwithotherACCURUNcontrolsinacustomcombination;onlycontainsLymeIgG,helpsmeetspecificneedsofQCprogram
• Madefromnaturallyoccurringplasmaorserum;closelyresemblesanactualpatientsample
• NonreactiveforHBsAgandantibodiestoHIV½,HTLV,andHCV
• AconsistentandreliablesourceofQCmaterial;helpsmaintaincomplianceandmeetregulatorycommitments
• Analytesincluded:Borreliaburgdorferi(Lyme)IgG
• Regulatoryclearance:IVD,CE,andHC

ACCURUNSerologycontrolsaresomeofthemostrespectedintheindustryandhavelongbeenreliedonbymanyworldclasslaboratories.ACCURUN130canhelpimproveconfidenceinyourtestresultsandassistinmaintainingregulatorycompliancewhenpartofyourlaboratory’squalityassuranceprogram.